22R-Hydroxycholesterol and 9-cis-Retinoic Acid Induce ATP-binding Cassette Transporter A1 Expression and Cholesterol Efflux in Brain Cells and Decrease Amyloid β Secretion*
暂无分享,去创建一个
S. DeKosky | J. Lazo | M. Ikonomovic | Barbara A. Isanski | I. Lefterov | R. Koldamova | J. Skoko | Preslav I. Lefterov
[1] M. Irizarry,et al. Induction of the Cholesterol Transporter ABCA1 in Central Nervous System Cells by Liver X Receptor Agonists Increases Secreted Aβ Levels* , 2002, The Journal of Biological Chemistry.
[2] Z. Balázs,et al. ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[3] Sascha Weggen,et al. The cytoplasmic domain of the LDL receptor‐related protein regulates multiple steps in APP processing , 2002, The EMBO journal.
[4] D. Mangelsdorf,et al. The liver X receptor gene team: Potential new players in atherosclerosis , 2002, Nature Medicine.
[5] J. Gustafsson,et al. Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Goldstein,et al. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. , 2002, Molecular cell.
[7] J. Leverenz,et al. Diet-induced hypercholesterolemia enhances brain A&bgr; accumulation in transgenic mice , 2002, Neuroreport.
[8] B. McManus,et al. ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation , 2002, Laboratory Investigation.
[9] S. Younkin,et al. Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains , 2002, Neurobiology of Disease.
[10] A. Zwinderman,et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study , 2002, The Lancet.
[11] Carrie M. Welch,et al. Preferential ATP-binding Cassette Transporter A1-mediated Cholesterol Efflux from Late Endosomes/Lysosomes* , 2001, The Journal of Biological Chemistry.
[12] C. Göritz,et al. CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.
[13] M. Hayden,et al. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. , 2001, Journal of lipid research.
[14] D. Riddell,et al. Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts , 2001, Current Biology.
[15] H. Brewer,et al. Cellular Localization and Trafficking of the Human ABCA1 Transporter* 210 , 2001, The Journal of Biological Chemistry.
[16] J. Lazo,et al. Cysteine 73 in bleomycin hydrolase is critical for amyloid precursor protein processing. , 2001, Biochemical and biophysical research communications.
[17] R. Lawn,et al. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. , 2001, Journal of lipid research.
[18] E. Kojro,et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Bergmann,et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Dietschy,et al. Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.
[21] H. Rigneault,et al. Specific Docking of Apolipoprotein A-I at the Cell Surface Requires a Functional ABCA1 Transporter* , 2001, The Journal of Biological Chemistry.
[22] T. Hudson,et al. Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease , 2001, Circulation.
[23] J. Herz. The LDL Receptor Gene Family (Un)Expected Signal Transducers in the Brain , 2001, Neuron.
[24] H. Brewer,et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. , 2001, Biochemical and biophysical research communications.
[25] A Rzhetsky,et al. The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Journal of lipid research.
[26] J. Oram. Tangier disease and ABCA1. , 2000, Biochimica et biophysica acta.
[27] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[28] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Tall,et al. Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.
[30] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[31] J. Mcneish,et al. The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.
[32] A. Tall,et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.
[33] J. Lazo,et al. Human bleomycin hydrolase regulates the secretion of amyloid precursor protein , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] D. S. Lin,et al. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production. , 2000, Journal of lipid research.
[35] R. Lawn,et al. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. , 2000, Biochemical and biophysical research communications.
[36] Rong Wang,et al. Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.
[37] B. Strooper,et al. Proteolytic processing and cell biological functions of the amyloid precursor protein. , 2000, Journal of cell science.
[38] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[39] D. Rader,et al. ABC1: connecting yellow tonsils, neuropathy, and very low HDL. , 1999, The Journal of clinical investigation.
[40] J. Dietschy,et al. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[42] D. Selkoe,et al. Mutagenesis Identifies New Signals for β-Amyloid Precursor Protein Endocytosis, Turnover, and the Generation of Secreted Fragments, Including Aβ42* , 1999, The Journal of Biological Chemistry.
[43] J M Guileyardo,et al. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] B. Strooper,et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[45] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[46] P. Ianna,et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. , 1997, The Biochemical journal.
[47] M. Nakai,et al. Expression of apolipoprotein E mRNA in rat microglia , 1996, Neuroscience Letters.
[48] A. K. Gayen,et al. The length of 5'-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate. , 1995, Archives of biochemistry and biophysics.
[49] D. Armstrong,et al. AMPA‐selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation , 1995, The Journal of comparative neurology.
[50] S. Gauthier,et al. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats , 1993, Neuroscience.
[51] R. E. Pitas,et al. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.
[52] D Giulian,et al. Characterization of ameboid microglia isolated from developing mammalian brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[53] G. Banker,et al. Immunocytochemical localization of tubulin and microtubule-associated protein 2 during the development of hippocampal neurons in culture , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] W. Maxwell Cowan,et al. Rat hippocampal neurons in dispersed cell culture , 1977, Brain Research.
[55] F. Jessen,et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. , 2002, Journal of psychiatric research.
[56] M. Jaye,et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.
[57] R. Evans,et al. A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .
[58] G. Schroepfer,et al. Oxysterols: modulators of cholesterol metabolism and other processes. , 2000, Physiological reviews.
[59] J. Poirier,et al. Brain lipoprotein metabolism and its relation to neurodegenerative disease. , 1999, Critical reviews in neurobiology.